Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors

NCT00800345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Gynecologic Tumors

Interventions

DRUG: Oral Topotecan
DRUG: Pazopanib

Sponsor

Vector Oncology

Collaborators

[object Object]